NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

These market value estimates are put together by outfits who are trying to sell their reports. The potential size of the glioblastoma market depends on the underlying estimates used to derive the market potential.

Here is another outfit that values the potential market size at $3.3 billion by 2024:

https://www.biospace.com/article/releases/glioblastoma-treatment-market-will-expand-to-3-3-billion-by-2024-b-globaldata-b-report-says-/

DCVax is a platform technology that could potentially be used for almost every operable and inoperable solid tumor. The potential market size is a lot higher than $1.15 billion or even $3.30 billion
IMO.